C O L D S H O U L D E R Yalow wanted to attend medical
school, but her family encouraged her to become an elementary school teacher -an idea she opposed. Graduate school was another option, but she felt it was unlikely that any good graduate school would offer financial support for a woman in physics. Nevertheless, she submitted applications to several universities, all meeting with prompt rejection. One response was particularly blunt: "She is from New York. She is Jewish. She is a woman." With few other options, Yalow enrolled in stenography courses and took a part-time position as a secretary.
As secretary to Rudolf Schoenheimer, a leading biochemist at Columbia University, Yalow was tantalisingly close to academe. Her dreams were realised when, shortly after starting her secretarial duties, she was offered a graduate student position and teaching assistantship in physics at the University of Illinois. "It was an achievement beyond belief," she recalled. "I tore up my stenography books" and moved to Urbana-Champaign, Illinois.
At the University of Illinois, she was the first female graduate student in physics in nearly 40 years. Had World War II recruitment not winnowed the ranks of young male graduate students, she might never have been accepted. She faced scepticism as the lone woman among the 400 faculty members of the College of Engineering. 
D A R I N G H Y P O T H E S I S Yalow and Berson's first
investigations involved the application of radioisotopes to blood volume determination, diagnosis of thyroid diseases, and the kinetics of iodine metabolism. With time, their research extended to studies of the distribution of globulins and other serum proteins. They focused on insulin, a small peptide that was readily available Rosalyn Yalow in a highly purified form. It was a hormone of particular interest to Yalow, whose husband was a diabetic. In the 1950s, bovine insulin was used to treat diabetes mellitus, but scientists knew that patients developed resistance to it over time. Yalow and Berson hypothesised that the foreign insulin stimulated the production of antibodies. To study this, they first tagged molecules of bovine insulin with radioactive iodine. After injecting trace amounts into diabetic and non-diabetic volunteers, they then measured radioactivity in serial blood specimens. Clearance of the tagged insulin molecules was slower in the diabetic cohort. Further analysis showed that serum globulins had bound the radiolabelled insulin, confirming their hypothesis. The significance of the experiment was threefold. First, they demonstrated an underlying cause of resistance to bovine insulin. Second, they showed that a peptide as small as insulin could generate an immune response. Third, they demonstrated this finding using a novel new technique, which they termed 'radioimmunoassay'.
Never before had radioisotopic techniques been used to demonstrate the primary reaction between antibodies and antigens in solution. Alternative techniques employed secondary measures that required a visible reaction, such as the precipitation or agglutination of antigen-antibody complexes. Radioimmunoassay allowed for detection of far smaller quantities of antigen than these methods. Yalow persevered, and the findings were eventually published in 1959. In the years that followed, radioimmunoassay would become an essential tool for researchers across the full spectrum of biological sciences. 
EGALITARIAN CONVICTIONS

M E D I C A L G I A N T , M E D I C A L V I C T I M It
happened four years after Yalow's mandatory retirement from the VA hospital at the age of 70 and three years since the passing of her husband. She was rushed by ambulance to a nearby university hospital. She had lectured there on several occasions, and the university had awarded her an honorary degree. "The house officer in the emergency room didn't remember her name," recalled Yalow's friend and fellow physician Eugene Straus. "But he remembered a rather dirty old lady who had suffered a stroke. They refused to admit her… she had been 'dumped.' " The Nobel Prize-winning scientist, unconscious and unrecognised after suffering an ischaemic stroke, was then transferred to a second hospital for admission. Yalow regained consciousness after five days and left the hospital two weeks later. She would go on to live until the age of 90, dying on 30 May 2011.
